Search results
Results from the WOW.Com Content Network
Laboratory experiments have suggested that cannabis and cannabinoids have anticarcinogenic and antitumor effects, [22] including a potential effect on breast- and lung-cancer cells. [23] While cannabis may have potential for refractory cancer pain or use as an antiemetic, much of the evidence comes from outdated or small studies, or animal ...
Cancer Research UK say that while cannabis is being studied for therapeutic potential, "claims that there is solid "proof" that cannabis or cannabinoids can cure cancer is highly misleading to patients and their families, and builds a false picture of the state of progress in this area". [156]
A 2012 special report by the British Lung Foundation concluded that cannabis smoking was linked to many adverse effects, including bronchitis and lung cancer. [83] They identified cannabis smoke as a carcinogen and also said awareness of the danger was low compared with the high awareness of the dangers of smoking tobacco particularly among ...
The analysis showed that people with cannabis use disorder were about 2.5 times more likely to develop an oral cancer; nearly five times more likely to develop oropharyngeal cancer, which is ...
Story at a glance Marijuana for medical use has been legalized in many states. Cancer patients in particular may benefit from medical marijuana for managing pain and symptoms. An analysis of ...
Cannabis smoke was listed as a cancer agent in California in 2009. [31] A study by the British Lung Foundation published in 2012 identifies cannabis smoke as a carcinogen and also finds awareness of the danger is low compared with the high awareness of the dangers of smoking tobacco particularly among younger users.
A new study found evidence that marijuana could potentially be used to fight skin cancer, slowing the disease’s growth and killing cancerous cells before they have a chance to spread. But the ...
] CBC has shown antitumor effects in breast cancer xenoplants in mice. [7] It also has anticonvulsant activity in a mouse model. [8] In vitro, CBC binds weakly to CB1 and CB2 with binding affinities of 713 nM and 256 nM, respectively, which are significantly lower than that for THC with 35 nM at CB1.